BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20002447)

  • 21. Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage.
    Fung M; Lu M; Fure H; Sun W; Sun C; Shi NY; Dou Y; Su J; Swanson X; Mollnes TE
    Clin Exp Immunol; 2003 Aug; 133(2):160-9. PubMed ID: 12869020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinal microenvironment controls resident and infiltrating macrophage function during uveoretinitis.
    Robertson MJ; Erwig LP; Liversidge J; Forrester JV; Rees AJ; Dick AD
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2250-7. PubMed ID: 12091424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.
    Wang Y; Hu Q; Madri JA; Rollins SA; Chodera A; Matis LA
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8563-8. PubMed ID: 8710910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement-5 Inhibition Deters Progression of Fulminant Hepatitis to Acute Liver Failure in Murine Models.
    Kusakabe J; Hata K; Miyauchi H; Tajima T; Wang Y; Tamaki I; Kawasoe J; Okamura Y; Zhao X; Okamoto T; Tsuruyama T; Uemoto S
    Cell Mol Gastroenterol Hepatol; 2021; 11(5):1351-1367. PubMed ID: 33444818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies directed against human C5 and C8 block complement-mediated damage of xenogeneic cells and organs.
    Rollins SA; Matis LA; Springhorn JP; Setter E; Wolff DW
    Transplantation; 1995 Dec; 60(11):1284-92. PubMed ID: 8525523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats.
    Miyazaki A; Kitaichi N; Ohgami K; Iwata D; Jin XH; Iwabuchi K; Morohashi T; Ohno S; Onoé K
    Graefes Arch Clin Exp Ophthalmol; 2008 May; 246(5):747-57. PubMed ID: 18087711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
    Caspi RR; Roberge FG; Chan CC; Wiggert B; Chader GJ; Rozenszajn LA; Lando Z; Nussenblatt RB
    J Immunol; 1988 Mar; 140(5):1490-5. PubMed ID: 3346541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis.
    Sprong T; Brandtzaeg P; Fung M; Pharo AM; Høiby EA; Michaelsen TE; Aase A; van der Meer JW; van Deuren M; Mollnes TE
    Blood; 2003 Nov; 102(10):3702-10. PubMed ID: 12881318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.
    De Vries B; Matthijsen RA; Wolfs TG; Van Bijnen AA; Heeringa P; Buurman WA
    Transplantation; 2003 Feb; 75(3):375-82. PubMed ID: 12589162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of monoclonal antibodies directed at cell surface molecules on murine experimental autoimmune uveoretinitis.
    Ando K; Fujino Y; Mochizuki M
    Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):848-54. PubMed ID: 10502060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of complement component C5 protects porcine chondrocytes from xenogeneic rejection.
    Sommaggio R; Pérez-Cruz M; Brokaw JL; Máñez R; Costa C
    Osteoarthritis Cartilage; 2013 Dec; 21(12):1958-67. PubMed ID: 24041966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of anti-C5 antibody on recuperation from ischemia/reperfusion-induced acute kidney injury.
    Zilberman-Itskovich S; Abu-Hamad R; Stark M; Efrati S
    Ren Fail; 2019 Nov; 41(1):967-975. PubMed ID: 31662004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of sex hormones on experimental autoimmune uveoretinitis (EAU).
    Buggage RR; Matteson DM; Shen DF; Sun B; Tuaillon N; Chan CC
    Immunol Invest; 2003 Nov; 32(4):259-73. PubMed ID: 14603994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis.
    Camelo S; Lajavardi L; Bochot A; Goldenberg B; Naud MC; Brunel N; Lescure B; Klein C; Fattal E; Behar-Cohen F; de Kozak Y
    J Ocul Pharmacol Ther; 2009 Feb; 25(1):9-21. PubMed ID: 19232006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel pathogenic RBP-3 peptide reveals epitope spreading in persistent experimental autoimmune uveoretinitis.
    Boldison J; Khera TK; Copland DA; Stimpson ML; Crawford GL; Dick AD; Nicholson LB
    Immunology; 2015 Oct; 146(2):301-11. PubMed ID: 26152845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The B subunit of Escherichia coli heat-labile enterotoxin inhibits Th1 but not Th17 cell responses in established experimental autoimmune uveoretinitis.
    Raveney BJ; Richards C; Aknin ML; Copland DA; Burton BR; Kerr E; Nicholson LB; Williams NA; Dick AD
    Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4008-17. PubMed ID: 18469197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential contribution of C5aR and C5b-9 pathways to renal thrombic microangiopathy and macrovascular thrombosis in mice carrying an atypical hemolytic syndrome-related factor H mutation.
    Ueda Y; Miwa T; Ito D; Kim H; Sato S; Gullipalli D; Zhou L; Golla M; Song D; Dunaief JL; Palmer MB; Song WC
    Kidney Int; 2019 Jul; 96(1):67-79. PubMed ID: 30910380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterizing the original anti-C5 function-blocking antibody, BB5.1, for species specificity, mode of action and interactions with C5.
    Zelek WM; Menzies GE; Brancale A; Stockinger B; Morgan BP
    Immunology; 2020 Oct; 161(2):103-113. PubMed ID: 32557571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory effects of IFN-β on the development of experimental autoimmune uveoretinitis in B10RIII mice.
    Sun M; Yang Y; Yang P; Lei B; Du L; Kijlstra A
    PLoS One; 2011 May; 6(5):e19870. PubMed ID: 21573074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C5 inhibition prevents renal failure in a mouse model of lethal C3 glomerulopathy.
    Williams AL; Gullipalli D; Ueda Y; Sato S; Zhou L; Miwa T; Tung KS; Song WC
    Kidney Int; 2017 Jun; 91(6):1386-1397. PubMed ID: 28139294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.